Alzheimer's Disease

Patient and a family member at the Huger Mercy Care Center.

According to the Alzheimer’s Association, as many as 5.4 million people in the United States are living with Alzheimer’s disease, and 10 million baby boomers will develop the disease in their lifetime. As one of the top-10 causes of death, it is the only disease that currently cannot be prevented, cured or even slowed. Alzheimer’s disease is a looming medical and financial crisis for individuals, families and for society as a whole.

But, Barrow Neurological Institute is offering new hope for patients and family members whose lives have been impacted by Alzheimer’s. The doctors and scientists at Barrow are working to better understand Alzheimer’s, to diagnose the disease earlier, develop new treatments to slow its progression, and continue achieving milestones that will, someday, lead to a cure.

At Barrow, research and treatment for Alzheimer’s and other cognitive disorders are intertwined into one program in order to provide the best possible care for patients. Barrow scientists are exploring Alzheimer’s disease biomarkers, performing groundbreaking research on immunotherapy studies, and building a clinical trials program to better understand the ways Alzheimer’s and cognitive disorders damage the brain.

Your gift supporting the Alzheimer’s and Cognitive Disorders Program helps provide the highest level of convenience and care to all patients—and their family members—throughout the many difficult stages of memory impairment.

Meet Dr. Sabbagh

Dr. Marwan Sabbagh, director of Barrow's Alzheimer’s and Cognitive Disorders Program.

Marwan Sabbagh, MD, joins Barrow as the director of its Alzheimer’s and Cognitive Disorders Program. He is one of Arizona’s most admired and respected Alzheimer’s disease physicians and scientists.

Learn more.

Dementia with Dignity

Huger Mercy Living Center offers patients a real home.

Read more.

© 1996 - 2017 Barrow Neurological Foundation. All Rights Reserved.